scispace - formally typeset
B

Barbara S. Kirschner

Researcher at University of Chicago

Publications -  131
Citations -  14457

Barbara S. Kirschner is an academic researcher from University of Chicago. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 46, co-authored 129 publications receiving 13523 citations. Previous affiliations of Barbara S. Kirschner include Baylor College of Medicine & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

TL;DR: It is shown that a frameshift mutation caused by a cytosine insertion, 3020insC, which is expected to encode a truncated NOD2 protein, is associated with Crohn's disease, and a link between an innate immune response to bacterial components and development of disease is suggested.
Journal Article

Development and validation of a pediatric Crohn's disease activity index.

TL;DR: This paper used clinical and laboratory observations of 133 children and adolescents with Crohn's disease to validate an index of severity of illness previously developed by a group of senior pediatric gastroenterologists at a research forum in April 1990.
Journal ArticleDOI

Development and Validation of a Pediatric Crohnʼs Disease Activity Index

TL;DR: It is proposed that the PCDAI could be used in multicenter projects to facilitate patient stratification by disease severity and that longitudinalPCDAI scores might provide a numerical measure of response to therapeutic regimens.
Journal ArticleDOI

Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry.

TL;DR: This demographically diverse pediatric IBD cohort revealed age-related variation in the distribution of IBD phenotype, with a high prevalence of isolated colonic disease in young children.
Journal ArticleDOI

Common variants at five new loci associated with early-onset inflammatory bowel disease.

TL;DR: The results of a genome-wide association study in early-onset IBD involving 3,426 affected individuals and 11,963 genetically matched controls recruited through international collaborations in Europe and North America are reported, thereby extending the results from a previous study of 1,011 individuals with early-onset IBD.